NCT06444152View on ClinicalTrials.gov

Prevalence of Epstein-Barr Virus Infection

Active, not recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

December 20, 2025

Study Completion Date

December 20, 2025

Conditions
Lymph Node Excision Biopsy
Interventions
OTHER

Sample analysis

This study is analyzing stored samples

Trial Locations (1)

267

University of Botswana, Gaborone

All Listed Sponsors
collaborator

University of Botswana

OTHER

lead

University of Pennsylvania

OTHER

NCT06444152 - Prevalence of Epstein-Barr Virus Infection | Biotech Hunter | Biotech Hunter